Skip to content

Artivion AORT Free cash flow yield

Free cash flow yield at other companies

Abbott logo
AbbottABT
4.1%+1.2pp
Edwards Lifesciences logo
Edwards LifesciencesEW
2.4%
LeMaitre Vascular logo
LeMaitre VascularLMAT
3.2%+1.0pp
Medtronic logo
MedtronicMDT
5.2%+0.4pp
ITG
Integer HoldingsITGR
3.3%+0.6pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
5.4%+2.5pp

Other financials

Income statement

See full
Revenue$116.3M+17.5%
Gross profit$75.4M+18.7%
Operating income$5.8M+170%
Net income$1.4M+381%
EPS (diluted)$0.03+400%

Balance sheet

See full
Cash & equivalents$55.8M+47.9%
Total debt$258.2M-28.8%
Total equity$450.5M+53.1%
Total assets$883.2M+11.6%

Cash flow

See full
Operating cash flow$1.2M+107%
CapEx$8.0M+120%
Free cash flow-$6.8M+66.7%

Valuation

See full
Market cap$1.07B-24.8%
Enterprise value$1.27B-27.2%
P/E91.5×
P/S2.3×-1.3×

Profitability

See full
Gross margin64.6%+0.6pp
Operating margin8.2%+4.1pp
Net margin2.5%+1.5pp
FCF margin-0.1%-2.5pp

Returns & leverage

See full
Return on equity3.1%+1.8pp
Debt / equity0.6×-0.7×
Current ratio3.9×-1.7×

Where this comes from

Calculated from Artivion’s reported figures.

Based on trailing twelve months.

The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artivion's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artivion's free cash flow yield?
Artivion (AORT) reported free cash flow yield of -0% in Q1 2025.
How has Artivion's free cash flow yield changed year-over-year?
Artivion's free cash flow yield decreased by 104.1% year-over-year, from 1% to -0%.
What is the long-term trend for Artivion's free cash flow yield?
Over 4 years (2020 to 2024), Artivion's free cash flow yield has grown at a 14.2% compound annual growth rate (CAGR), from 0.5% to 0.9%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.